Search

Displaying results 5881 - 5890 of 10000 in total
  1. Drug

    Tilia cordata pollen

    go.drugbank.com/drugs/DB10954
    Approved

    Tilia cordata pollen is mainly used in allergenic testing.

  2. Drug

    Hordeum vulgare pollen

    go.drugbank.com/drugs/DB10961
    Approved

    Hordeum vulgare pollen is mainly used in allergenic testing.

  3. Drug

    Pseudotsuga menziesii pollen

    go.drugbank.com/drugs/DB10986
    Approved

    Pseudotsuga menziesii pollen is mainly used in allergenic testing.

  4. Drug

    Maclura pomifera pollen

    go.drugbank.com/drugs/DB10988
    Approved

    Maclura pomifera pollen is mainly used in allergenic testing.

  5. Drug

    M0002

    go.drugbank.com/drugs/DB05091
    Investigational

    M0002 is an orally-active selective vasopressin antagonist that inhibits water re-absorption from the kidneys.

  6. Drug

    Plinabulin

    go.drugbank.com/drugs/DB05992
    Investigational

  7. Drug

    AVAC

    go.drugbank.com/drugs/DB05441
    Experimental

    It has been tested in uses related to asthma and in treating eczema and atopic dermatitis.

  8. Drug

    Isothipendyl

    go.drugbank.com/drugs/DB08802
    Investigational

    Isothipendyl is an antihistamine and anticholinergic used as an antipruritic.

  9. Drug

    JNJ-42165279

    go.drugbank.com/drugs/DB15173
    Investigational

    Jnj-42165279 is under investigation in clinical trial NCT02498392 (An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress).

  10. Drug

    Tesaglitazar

    go.drugbank.com/drugs/DB06536
    Investigational

    Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. … Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.